Chifuyu Ushiyama

1.9k total citations
36 papers, 1.5k citations indexed

About

Chifuyu Ushiyama is a scholar working on Immunology, Nephrology and Epidemiology. According to data from OpenAlex, Chifuyu Ushiyama has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Nephrology and 9 papers in Epidemiology. Recurrent topics in Chifuyu Ushiyama's work include Chronic Kidney Disease and Diabetes (9 papers), Renal Diseases and Glomerulopathies (9 papers) and Sepsis Diagnosis and Treatment (8 papers). Chifuyu Ushiyama is often cited by papers focused on Chronic Kidney Disease and Diabetes (9 papers), Renal Diseases and Glomerulopathies (9 papers) and Sepsis Diagnosis and Treatment (8 papers). Chifuyu Ushiyama collaborates with scholars based in Japan, United States and South Korea. Chifuyu Ushiyama's co-authors include Noriaki Shimada, Tsukasa Nakamura, Hikaru Koide, Isao Ebihara, Masanori Hara, Shingo Suzuki, Shingo Suzuki, Shiwori Osada, Hisataka Shoji and Keiko Sekizuka and has published in prestigious journals such as Blood, The Journal of Immunology and Diabetes Care.

In The Last Decade

Chifuyu Ushiyama

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chifuyu Ushiyama Japan 20 619 356 290 249 227 36 1.5k
Leopoldo Ardiles Chile 15 554 0.9× 396 1.1× 224 0.8× 78 0.3× 197 0.9× 56 1.4k
Simona Buelli Italy 22 747 1.2× 377 1.1× 524 1.8× 103 0.4× 175 0.8× 27 1.6k
Joris Grond Netherlands 26 531 0.9× 359 1.0× 207 0.7× 210 0.8× 98 0.4× 53 1.7k
Elsa Valderrama United States 27 533 0.9× 527 1.5× 129 0.4× 240 1.0× 142 0.6× 98 2.1k
Kiyoki Kitagawa Japan 18 641 1.0× 312 0.9× 429 1.5× 102 0.4× 104 0.5× 35 1.5k
Katsushige Abe Japan 23 702 1.1× 396 1.1× 522 1.8× 131 0.5× 83 0.4× 42 1.7k
Thomas Sitter Germany 23 659 1.1× 209 0.6× 232 0.8× 129 0.5× 88 0.4× 76 1.5k
Minoru Sakatsume Japan 23 613 1.0× 620 1.7× 621 2.1× 101 0.4× 72 0.3× 70 2.0k
Joseph C.K. Leung Hong Kong 29 1.3k 2.1× 637 1.8× 457 1.6× 175 0.7× 95 0.4× 81 2.6k
Yuansheng Xie China 16 544 0.9× 292 0.8× 135 0.5× 118 0.5× 70 0.3× 40 1.1k

Countries citing papers authored by Chifuyu Ushiyama

Since Specialization
Citations

This map shows the geographic impact of Chifuyu Ushiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chifuyu Ushiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chifuyu Ushiyama more than expected).

Fields of papers citing papers by Chifuyu Ushiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chifuyu Ushiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chifuyu Ushiyama. The network helps show where Chifuyu Ushiyama may publish in the future.

Co-authorship network of co-authors of Chifuyu Ushiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Chifuyu Ushiyama. A scholar is included among the top collaborators of Chifuyu Ushiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chifuyu Ushiyama. Chifuyu Ushiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakamura, Tsukasa, Chifuyu Ushiyama, Yuriko Suzuki, et al.. (2003). Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin- resistant Staphylococcus aureus. Journal of Hospital Infection. 53(1). 58–63. 33 indexed citations
2.
Nakamura, Tsukasa, Chifuyu Ushiyama, Yoshimasa Suzuki, et al.. (2003). Hemoperfusion with Polymyxin B-Immobilized Fiber in Septic Patients with Methicillin-Resistant <i>Staphylococcus aureus</i>-Associated Glomerulonephritis. Nephron Clinical Practice. 94(2). c33–c39. 24 indexed citations
3.
Nakamura, Tsukasa, Chifuyu Ushiyama, Yoshimasa Suzuki, et al.. (2002). Hemoperfusion with Polymyxin B Immobilized Fibers for Urinary Albumin Excretion in Septic Patients with Trauma. ASAIO Journal. 48(3). 244–248. 22 indexed citations
4.
Nakamura, Tsukasa, Chifuyu Ushiyama, Shiwori Osada, et al.. (2002). Effect of Dilazep Dihydrochloride on Serum Cardiac Troponin T Levels in Hemodialysis Patients. Kidney & Blood Pressure Research. 25(1). 50–54. 9 indexed citations
5.
Nakamura, Tsukasa, Chifuyu Ushiyama, Hisataka Shoji, & Hikaru Koide. (2002). Effects of Hemoperfusion on Serum Cardiac Troponin T Concentrations Using Polymyxin B-Immobilized Fibers in Septic Patients Undergoing Hemodialysis. ASAIO Journal. 48(1). 41–44. 15 indexed citations
6.
Nakamura, Tsukasa, Shingo Suzuki, Chifuyu Ushiyama, Noriaki Shimada, & Hikaru Koide. (2002). Effect of phosphodiesterase III inhibitor on plasma concentrations of endothelin-1 and tumour necrosis factor in patients with acute heart failure. Acta Cardiologica. 57(1). 19–21. 13 indexed citations
7.
Nakamura, Tsukasa, Chifuyu Ushiyama, Kaoru Hirokawa, et al.. (2001). Effect of Cerivastatin on Urinary Albumin Excretion and Plasma Endothelin-1 Concentrations in Type 2 Diabetes Patients with Microalbuminuria and Dyslipidemia. American Journal of Nephrology. 21(6). 449–454. 74 indexed citations
8.
Nakamura, Tsukasa, et al.. (2001). Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria. Metabolism. 50(10). 1193–1196. 107 indexed citations
9.
Nakamura, Tsukasa, Chifuyu Ushiyama, Shingo Suzuki, et al.. (2001). Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria. Diabetic Medicine. 18(4). 308–313. 55 indexed citations
10.
Nakamura, Tsukasa, Chifuyu Ushiyama, Shingo Suzuki, et al.. (2000). Elevation of Serum Levels of Metalloproteinase-1, Tissue Inhibitor of Metalloproteinase-1 and Type IV Collagen, and Plasma Levels of Metalloproteinase-9 in Polycystic Kidney Disease. American Journal of Nephrology. 20(1). 32–36. 63 indexed citations
11.
Nakamura, Tsukasa, Chifuyu Ushiyama, Shingo Suzuki, et al.. (2000). The Urinary Podocyte as a Marker for the Differential Diagnosis of Idiopathic Focal Glomerulosclerosis and Minimal-Change Nephrotic Syndrome. American Journal of Nephrology. 20(3). 175–179. 53 indexed citations
12.
Ushiyama, Chifuyu, Shingo Suzuki, Hisataka Shoji, et al.. (2000). POLYMYXIN B-IMMOBILIZED FIBER REDUCES INCREASED PLASMA ENDOTHELIN-1 CONCENTRATIONS IN HEMODIALYSIS PATIENTS WITH SEPSIS. Renal Failure. 22(2). 225–234. 5 indexed citations
13.
Ushiyama, Chifuyu, Shingo Suzuki, Masanori Hara, et al.. (2000). Urinary Podocytes for the Assessment of Disease Activity in Lupus Nephritis. The American Journal of the Medical Sciences. 320(2). 112–116. 69 indexed citations
14.
Nakamura, Tsukasa, Chifuyu Ushiyama, Shingo Suzuki, et al.. (2000). Effect of Plasma Exchange on Serum Tissue Inhibitor of Metalloproteinase 1 and Cytokine Concentrations in Patients with Fulminant Hepatitis. Blood Purification. 18(1). 50–54. 45 indexed citations
15.
Nakamura, Tsukasa, Chifuyu Ushiyama, Shingo Suzuki, et al.. (2000). Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy. American Journal of Nephrology. 20(5). 373–379. 59 indexed citations
16.
Nakamura, Tsukasa, Isao Ebihara, Hisataka Shoji, et al.. (1999). Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: Decrease in plasma levels of soluble P-selectin, platelet factor 4 and β-thromboglobulin. Inflammation Research. 48(4). 171–175. 56 indexed citations
17.
Hattori, Koichi, T Hirano, Chifuyu Ushiyama, et al.. (1999). A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation. Bone Marrow Transplantation. 23(12). 1283–1289. 11 indexed citations
18.
Abe, Kaori, Yoshinari Takasaki, Chifuyu Ushiyama, et al.. (1999). Expression of CD80 and CD86 on Peripheral Blood T Lymphocytes in Patients with Systemic Lupus Erythematosus. Journal of Clinical Immunology. 19(1). 58–66. 21 indexed citations
19.
Nakamura, Tsukasa, Isao Ebihara, Noriaki Shimada, et al.. (1998). Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock. Journal of Infection. 37(3). 241–247. 15 indexed citations
20.
Miyajima, Hiroaki, et al.. (1996). IgE Allotypes in Sera of Mice with Autoimmune Diseases and in Mice with Graft-versus-Host Disease after Transfusion or Bone Marrow Transplantation. International Archives of Allergy and Immunology. 111(2). 152–155. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026